Latest filing published 10 Sept 2026 for InSilico Medicine Cayman TopCo, €112k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
ZAVORONKOVS Aleksandrs: trading record in brief
ZAVORONKOVS Aleksandrs discloses dealings in InSilico Medicine Cayman TopCo to HKEX. Over a trading history stretching from 30 December 2025 to 7 September 2026, the count stands at 3 filings.
Every open-market trade on record is a purchase: 2 purchases worth €610k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2026 to date brings 2 purchases and no sales.
Most recently, on 10 September 2026, the filings show an open-market purchase worth €112k in InSilico Medicine Cayman TopCo. Filings reach the HKEX feed a median of 5 days after the trade. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to ZAVORONKOVS Aleksandrs
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 21,000 shares@ HK$48.76ShareXHKGHKEX:DA20260910E00081Canonical exit: 6 Dec 2026 (T+90)
- 92,500 shares@ HK$48.98780.022% mcap100.0% of flowShareXHKGHKEX:DA20260909E00359Canonical exit: 3 Dec 2026 (T+90)
2 of 2 declarations